Sponsor:
Brigham and Women's Hospital
Code:
NCT03524222
Conditions
Infection
Heart Failure
COPD
Asthma
Gout Flare
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Home Hospitalization
Brief summary:
Conditions
Infection
Heart Failure
COPD
Asthma
Gout Flare
Study ID
NCT03524222
Start date
Jan 18, 2018
Status verified date
Mar, 2026
Completion date
Sep, 2031
Anticipated
Primary completion date
Sep, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
3000 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Home Hospitalization
Interventions
Home Hospitalization
Primary outcome measure
Central contacts
Locations
Brigham and Women's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Principal Investigator:
David M Levine, MD MPH MA
Brigham and Women's Faulkner Hospital
Recruiting
Boston, Massachusetts, United States, 02130
Contacts
Principal Investigator:
David M Levine, MD MPH MA
Sponsor
Brigham and Women's Hospital
Last update posted
Mar 17, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2026-03-17.